These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6386275)

  • 41. Antihypertensive effects and plasma levels of guanfacine in man.
    Safar ME; Loria Y; Weiss YA; Boutier JR
    J Clin Pharmacol; 1982; 22(8-9):385-90. PubMed ID: 6752213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hypotensive and hemodynamic effects of guanfacine in arterial hypertension].
    Erina EV; Beliakova EV; Charyev KhZ; Panfilov VV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):63-7. PubMed ID: 2663029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat.
    Thoolen MJ; Hendriks JC; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1983; 5(2):224-8. PubMed ID: 6188894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blood pressure and prolactin: effects of guanfacine. Three-year follow-up study.
    Hauger-Klevene JH; Pinkas MB; Gerber S
    Hypertension; 1981; 3(6 Pt 2):II-222-5. PubMed ID: 7028619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal by naloxone of the antihypertensive action of clonidine: involvement of the sympathetic nervous system.
    Farsang C; Kapocsi J; Vajda L; Varga K; Malisak Z; Fekete M; Kunos G
    Circulation; 1984 Mar; 69(3):461-7. PubMed ID: 6362905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension.
    Nami R; Bianchini C; Fiorella G; Chierichetti SM; Gennari C
    J Cardiovasc Pharmacol; 1983; 5(4):546-51. PubMed ID: 6193349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term antihypertensive therapy with guanfacine.
    Szám I; Holló J
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antihypertensive effect of guanfacine compared with methyldopa.
    van der Merwe CJ; Kruger SA
    S Afr Med J; 1980 Mar; 57(11):400-4. PubMed ID: 6105713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension].
    Kravchenko IG; Liashenko MM; Tarnakin AG; Chirkov SN
    Kardiologiia; 1986 Mar; 26(3):41-5. PubMed ID: 3520085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of guanfacine on ambulatory blood pressure and its variability in elderly patients with essential hypertension.
    Dupont AG; Vanderniepen P; Six RO
    Br J Clin Pharmacol; 1987 Apr; 23(4):397-401. PubMed ID: 3555578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic and cardiac haemodynamic interactions between guanfacine and hydrallazine in hypertensive patients.
    Velasco M; Urbina-Quintana A; Morillo J; Vizcarrondo H; Ramirez A; Hernández E; Hernández-Pieretti O
    Eur J Clin Pharmacol; 1984; 27(4):393-6. PubMed ID: 6394347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
    Hauger-Klevene JH; Balossi EC; Scornavacchi JC
    Cor Vasa; 1987; 29(4 Suppl 1):17-22. PubMed ID: 3119290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the actions of centrally and peripherally administered clonidine and guanfacine in the rabbit: investigation of the differences.
    Barber ND; Reid JL
    Br J Pharmacol; 1982 Dec; 77(4):641-7. PubMed ID: 6758908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
    Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
    Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonism of hypotensive and bradycardic effects of centrally administered guanfacine by metiamide in anesthetized rabbits.
    Otorii T; Ohkubo K; Suzuki K
    Jpn Heart J; 1985 Jul; 26(4):577-84. PubMed ID: 2865383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. beta-Endorphin and essential hypertension: importance of the clonidine-naloxone interaction.
    Farsang C; Kapocsi J; Varga K; Vajda L; Balás-Eltes A; Kunos G
    Acta Physiol Hung; 1985; 65(2):217-26. PubMed ID: 3157294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Naloxone enhances the increase in plasma growth hormone induced by alpha 2-adrenergic stimulation in healthy males.
    Bramnert M; Hökfelt B
    Acta Endocrinol (Copenh); 1987 Feb; 114(2):308-13. PubMed ID: 2881420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P; Lasance A
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M; Weiss Y; Georges D
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.